CN103180326B - 杂环化合物及其用途 - Google Patents

杂环化合物及其用途 Download PDF

Info

Publication number
CN103180326B
CN103180326B CN201180048970.3A CN201180048970A CN103180326B CN 103180326 B CN103180326 B CN 103180326B CN 201180048970 A CN201180048970 A CN 201180048970A CN 103180326 B CN103180326 B CN 103180326B
Authority
CN
China
Prior art keywords
alkyl
group
halogen atom
optionally substituted
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180048970.3A
Other languages
English (en)
Chinese (zh)
Other versions
CN103180326A (zh
Inventor
郡正城
今枝稔博
中村信二
丰福昌志
本多荣治
浅野恭臣
宇治川治
望月伦代
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Priority to CN201510259936.0A priority Critical patent/CN104926837A/zh
Publication of CN103180326A publication Critical patent/CN103180326A/zh
Application granted granted Critical
Publication of CN103180326B publication Critical patent/CN103180326B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CN201180048970.3A 2010-08-10 2011-08-09 杂环化合物及其用途 Active CN103180326B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510259936.0A CN104926837A (zh) 2010-08-10 2011-08-09 杂环化合物及其用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10
JP2010-179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510259936.0A Division CN104926837A (zh) 2010-08-10 2011-08-09 杂环化合物及其用途

Publications (2)

Publication Number Publication Date
CN103180326A CN103180326A (zh) 2013-06-26
CN103180326B true CN103180326B (zh) 2015-06-10

Family

ID=44534564

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201180048970.3A Active CN103180326B (zh) 2010-08-10 2011-08-09 杂环化合物及其用途
CN201510259936.0A Pending CN104926837A (zh) 2010-08-10 2011-08-09 杂环化合物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510259936.0A Pending CN104926837A (zh) 2010-08-10 2011-08-09 杂环化合物及其用途

Country Status (39)

Country Link
US (11) US8575154B2 (https=)
EP (1) EP2603513B1 (https=)
JP (2) JP5788496B2 (https=)
KR (1) KR101852215B1 (https=)
CN (2) CN103180326B (https=)
AR (1) AR082618A1 (https=)
AU (1) AU2011290126B2 (https=)
BR (1) BR112013002250B1 (https=)
CA (1) CA2807460C (https=)
CL (1) CL2013000380A1 (https=)
CO (1) CO6680700A2 (https=)
CR (1) CR20130066A (https=)
CY (1) CY1123507T1 (https=)
DK (1) DK2603513T3 (https=)
DO (1) DOP2013000030A (https=)
EA (1) EA022078B1 (https=)
EC (1) ECSP13012478A (https=)
ES (1) ES2793723T3 (https=)
GE (1) GEP20156216B (https=)
HR (1) HRP20200844T1 (https=)
HU (1) HUE049460T2 (https=)
IL (1) IL224452A (https=)
LT (1) LT2603513T (https=)
MA (1) MA34509B1 (https=)
MX (1) MX349470B (https=)
MY (1) MY165908A (https=)
NZ (1) NZ607593A (https=)
PE (1) PE20131116A1 (https=)
PH (1) PH12013500247A1 (https=)
PL (1) PL2603513T3 (https=)
PT (1) PT2603513T (https=)
RS (1) RS60311B1 (https=)
SG (1) SG187656A1 (https=)
SI (1) SI2603513T1 (https=)
TW (1) TWI504604B (https=)
UA (1) UA111594C2 (https=)
UY (1) UY33551A (https=)
WO (1) WO2012020848A1 (https=)
ZA (1) ZA201301120B (https=)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus
EP2694472B1 (en) * 2011-04-05 2020-03-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
JP6134654B2 (ja) * 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
EP3008167A4 (en) * 2013-06-13 2017-06-07 VeroScience LLC Compositions and methods for treating metabolic disorders
SG11201509186TA (en) 2013-06-27 2016-01-28 Pfizer Heteroaromatic compounds and their use as dopamine d1 ligands
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
CA2931961C (en) 2013-12-03 2023-10-31 Andrew Duncan Satterfield Pyrrolidinones as herbicides
SG11201610720VA (en) 2014-07-02 2017-01-27 Du Pont Piperidinone herbicides
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
EP3280709B1 (en) 2015-04-10 2021-05-26 FMC Corporation Substituted cyclic amides as herbicides
BR112017020094B1 (pt) 2015-04-27 2022-01-11 Fmc Corporation Composto, composições herbicidas, mistura de herbicida e método para controlar o crescimento de vegetação indesejada
RS61688B1 (sr) 2015-04-29 2021-05-31 Janssen Pharmaceutica Nv Azabenzimidazoli i njihiova upotreba kao modulatori ampa receptora
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
JP7000160B2 (ja) 2015-05-12 2022-01-19 エフ エム シー コーポレーション 除草剤としてのアリール置換二環式化合物
JP6869192B2 (ja) 2015-05-29 2021-05-12 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 除草剤としての置換環状アミド
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
JP6937290B2 (ja) 2015-07-31 2021-09-22 エフ エム シー コーポレーションＦｍｃ Ｃｏｒｐｏｒａｔｉｏｎ 除草剤として有用な環状ｎ−カルボキサミド化合物
CA2982825C (en) * 2015-08-06 2023-10-17 F. Hoffmann-La Roche Ag Processes for the preparation of galnac acid derivatives
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
RU2019122791A (ru) 2016-12-21 2021-01-25 Фмк Корпорейшн Гербициды на основе нитрона
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
MX2019010969A (es) 2017-03-21 2019-12-02 Fmc Corp Pirrolidinonas y proceso para prepararlas.
CN110740646B (zh) 2017-03-21 2022-05-10 Fmc公司 除草剂混合物、组合物和方法
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
ES2970624T3 (es) 2017-10-06 2024-05-29 Takeda Pharmaceuticals Co Compuesto heterocíclico
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
AU2020348675B2 (en) 2019-09-16 2025-11-20 Takeda Pharmaceutical Company Limited Azole-fused pyridazin-3(2H)-one derivatives
US20230338391A1 (en) * 2020-05-15 2023-10-26 Takeda Pharmaceutical Company Limited Treatment for depression
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders
WO2026050231A1 (en) 2024-08-27 2026-03-05 Neurocrine Biosciences, Inc. Method of treating a bipolar disorder

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564817A (zh) * 2001-10-10 2005-01-12 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
CN1606559A (zh) * 2001-12-21 2005-04-13 瑟维尔实验室 新的苯并噻嗪和苯并噻二嗪衍生物,其制备方法以及包含所述化合物的药物组合物
CN1798750A (zh) * 2003-05-05 2006-07-05 瑟维尔实验室 噻二嗪衍生物及其用作正ampa受体调节剂的用途
CN101541741A (zh) * 2006-12-11 2009-09-23 伊莱利利公司 Ampa受体增强剂
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
WO2009147167A1 (en) * 2008-06-06 2009-12-10 N.V. Organon Indane derivatives as ampa receptor modulators

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (https=) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
EP1229786A1 (en) 1999-11-04 2002-08-14 Colorado State University Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
US8487099B2 (en) * 2007-11-05 2013-07-16 Merck Sharp & Dohme Corp. Gamma secretase modulators
CA2709784A1 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2009119088A1 (ja) 2008-03-25 2009-10-01 武田薬品工業株式会社 複素環化合物
EP2356115A1 (en) * 2008-11-06 2011-08-17 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
EP2455380A4 (en) 2009-07-13 2012-11-28 Takeda Pharmaceutical HETEROCYCLIC COMPOUND AND USE THEREOF
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
LT2603513T (lt) * 2010-08-10 2020-05-25 Takeda Pharmaceutical Company Limited Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1564817A (zh) * 2001-10-10 2005-01-12 神经研究公司 新的苯并噻嗪衍生物、其制备和应用
CN1606559A (zh) * 2001-12-21 2005-04-13 瑟维尔实验室 新的苯并噻嗪和苯并噻二嗪衍生物,其制备方法以及包含所述化合物的药物组合物
CN1798750A (zh) * 2003-05-05 2006-07-05 瑟维尔实验室 噻二嗪衍生物及其用作正ampa受体调节剂的用途
CN101541741A (zh) * 2006-12-11 2009-09-23 伊莱利利公司 Ampa受体增强剂
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
WO2009147167A1 (en) * 2008-06-06 2009-12-10 N.V. Organon Indane derivatives as ampa receptor modulators

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
Recent Advances in the Discovery of Selective AMPA Receptor Positive Allosteric Modulators;Simon E. Ward,等;《Current Medicinal Chemistry》;20100101;第17卷(第30期);第3503-3513页 *
房长进.RN:303018-15-7.《STN REGISTRY数据库》.2000, *
房长进.RN:303019-30-9.《STN REGISTRY数据库》.2000, *
房长进.RN:315677-93-1.《STN REGISTRY数据库》.2001, *
房长进.RN:554406-78-9.《STN REGISTRY数据库》.2003, *
房长进.RN:565192-84-9.《STN REGISTRY数据库》.2003, *
房长进.RN:71518-03-1.《STN REGISTRY数据库》.1984, *
房长进.RN:726155-61-9.《STN REGISTRY数据库》.2004, *
房长进.RN:728898-87-1.《STN REGISTRY数据库》.2004, *
房长进.RN:732959-59-0.《STN REGISTRY数据库》.2004, *

Also Published As

Publication number Publication date
MA34509B1 (fr) 2013-09-02
US8916551B2 (en) 2014-12-23
CN104926837A (zh) 2015-09-23
CA2807460A1 (en) 2012-02-16
RS60311B1 (sr) 2020-07-31
CR20130066A (es) 2013-05-03
JP2016006080A (ja) 2016-01-14
GEP20156216B (en) 2015-01-12
CN103180326A (zh) 2013-06-26
UY33551A (es) 2012-03-30
MX349470B (es) 2017-07-31
US9150591B2 (en) 2015-10-06
CL2013000380A1 (es) 2013-05-31
US20240360156A1 (en) 2024-10-31
ES2793723T3 (es) 2020-11-16
KR20130138738A (ko) 2013-12-19
NZ607593A (en) 2015-01-30
JP5788496B2 (ja) 2015-09-30
PT2603513T (pt) 2020-06-08
MX2013001614A (es) 2013-07-05
US8778934B2 (en) 2014-07-15
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
DOP2013000030A (es) 2013-03-15
US20140080817A1 (en) 2014-03-20
TW201217386A (en) 2012-05-01
ZA201301120B (en) 2014-04-30
AR082618A1 (es) 2012-12-19
AU2011290126A1 (en) 2013-03-07
JP6113789B2 (ja) 2017-04-12
AU2011290126B2 (en) 2016-01-07
CA2807460C (en) 2018-09-18
PH12013500247A1 (en) 2013-03-11
HUE049460T2 (hu) 2020-09-28
DK2603513T3 (da) 2020-06-15
WO2012020848A8 (en) 2012-09-27
US20180162875A1 (en) 2018-06-14
US11279713B2 (en) 2022-03-22
US10654874B2 (en) 2020-05-19
ECSP13012478A (es) 2013-04-30
MY165908A (en) 2018-05-18
EA201390222A1 (ru) 2013-08-30
LT2603513T (lt) 2020-05-25
SG187656A1 (en) 2013-03-28
EP2603513B1 (en) 2020-03-11
JP2013535408A (ja) 2013-09-12
CO6680700A2 (es) 2013-05-31
US8575154B2 (en) 2013-11-05
US20130190291A1 (en) 2013-07-25
US20190263832A1 (en) 2019-08-29
PL2603513T3 (pl) 2020-07-27
US20150073137A1 (en) 2015-03-12
US20120077799A1 (en) 2012-03-29
US20200317692A1 (en) 2020-10-08
BR112013002250A2 (pt) 2016-05-24
US20170022222A1 (en) 2017-01-26
US9499568B2 (en) 2016-11-22
US9884875B2 (en) 2018-02-06
CY1123507T1 (el) 2022-03-24
US20130184266A1 (en) 2013-07-18
PE20131116A1 (es) 2013-10-24
EA022078B1 (ru) 2015-10-30
WO2012020848A1 (en) 2012-02-16
HRP20200844T1 (hr) 2020-08-21
TWI504604B (zh) 2015-10-21
IL224452A (en) 2017-11-30
BR112013002250B1 (pt) 2020-10-27
US20150353578A1 (en) 2015-12-10
KR101852215B1 (ko) 2018-04-25
EP2603513A1 (en) 2013-06-19

Similar Documents

Publication Publication Date Title
CN103180326B (zh) 杂环化合物及其用途
CN111148746B (zh) 杂环化合物
JPWO2009157196A1 (ja) アミド化合物
EP2813508B1 (en) Heterocyclic compound and use thereof
TW202220978A (zh) 雜環化合物
HK1182701B (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
HK1182701A (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant